Since it has been shown that treatment with APR-246 consumes GSH reserves and causes an increase in ROS [25], the simultaneous blockade of xCT function, not allowing cancer cells to counterbalance this oxidative stress, exerts a synergistic effect (Figure 7, right panel). This evidence concerns the gene SLC7A11 and cancer.